Congress Asset Management’s NeoGenomics NEO Stock Holding History
Bought
Maintained
Sold
Other funds holding NEO
GE
FLAM
GIP
FPC
EA
Congress Asset Management's NEO Position: Q4 2017 in Review
Congress Asset Management sold out of NeoGenomics (NEO) in Q4 2017, closing a stake of 117,762 shares — an estimated $1.31M sold.
Congress Asset Management first reported a position in NEO in Q3 2017 and held it in 1 quarter. The position peaked at $1.31M in Q3 2017. 132 funds tracked by Wall St. Rank hold NEO as of Q4 2017.
- Congress Asset Management reported no remaining NeoGenomics position as of Q4 2017 after selling out during the quarter.
- Congress Asset Management sold 117,762 NeoGenomics shares in Q4 2017, an estimated $1.31M.
- Congress Asset Management first reported a position in NeoGenomics in Q3 2017 and held it in 1 quarter.
- Congress Asset Management's NeoGenomics position peaked at $1.31M in Q3 2017.
- 132 funds tracked by Wall St. Rank held NeoGenomics as of Q4 2017.
Based on Congress Asset Management's 13F filing for Q4 2017, filed 30 Jan 2018.